CN108823164A - Induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell - Google Patents

Induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell Download PDF

Info

Publication number
CN108823164A
CN108823164A CN201810817902.2A CN201810817902A CN108823164A CN 108823164 A CN108823164 A CN 108823164A CN 201810817902 A CN201810817902 A CN 201810817902A CN 108823164 A CN108823164 A CN 108823164A
Authority
CN
China
Prior art keywords
cell
neural progenitor
progenitor cell
serum
differentiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810817902.2A
Other languages
Chinese (zh)
Inventor
甄威
刘子铖
王楠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
93 Pole Constant Biological Medicine Science And Technology Jiangsu Co Ltd
Original Assignee
93 Pole Constant Biological Medicine Science And Technology Jiangsu Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 93 Pole Constant Biological Medicine Science And Technology Jiangsu Co Ltd filed Critical 93 Pole Constant Biological Medicine Science And Technology Jiangsu Co Ltd
Priority to CN201810817902.2A priority Critical patent/CN108823164A/en
Publication of CN108823164A publication Critical patent/CN108823164A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0623Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/13Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/15Transforming growth factor beta (TGF-β)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/85Hormones derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

It the invention belongs to stem cell biology and technical field of cell culture, proposes and promotes to induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell, specifically include serum-free differentiation minimal medium and promote the additive of nerve group cell differentiation.Wherein, serum-free minimal medium neccessary composition includes:DMEM/F12 culture medium, human serum albumins, L-Glutamine, D-Glucose, vitamin C, N2/B27 cell culture additive, nonessential amino acid.The additive of neural progenitor cell differentiation is promoted to specifically include:SB431542, dermorphin, Fibroblast growth factors 2, vitamin A acid, brain-derived neurotrophic factor.The differentiation of the neural progenitor cell in mixing with cells system can be helped to improve with this culture medium, the differentiation to other types cell is reduced, to finally obtain the neural progenitor cell of high-purity.

Description

Induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell
Technical field
The invention belongs to stem cell biologies and technical field of cell culture, relate in particular to a kind of for promoting induction The serum free culture system that multipotential stem cell breaks up to neural progenitor cell.
Background technique
Neurodegenerative disease is a kind of slowly onset, the course of disease in the disease for carrying out sexual development, prognosis mala, is still lacked so far Effective radical cure method.Clinical common neurodegenerative disease has Parkinson's disease, amyotrophic lateral sclerosis, spinal muscular atrophy With Alzheimer disease etc..Though these disease causes of disease are different but pathologically having nervous centralis different parts and different degrees of N euron loss and dysfunction.The neuron lost is substituted, functional rehabilitation is allowed to, is the new approaches for treating this kind of disease.Closely The stem cell of research discovery in vitro culture over year can not only be proliferated, break up, but also " transdifferentiation ", Ye Jiyi can occur The tissue-derived cell of kind can be divided into other incoherent tissue cell types.For example, candidate stem cell, mesenchyma are dry thin Born of the same parents etc. can be to mature neural cellular differentiation under certain conditions in vitro.Experiment in vivo also confirms that neural stem cell or non-nerve Tissue-derived stem cell transplantation, which enters, can be divided into mature nerve cell, newborn nerve cell energy in impaired brain tissue The cells play function of substituting missing, provides new treatment method for this kind of nervous system refractory disease.
In histology engineering and clinical treatment, inductive pluripotent stem cells can theoretically induce differentiation into all kinds of nerves Cell, these cells can be widely applied to the reparation of tissue nervous system and reconstruction atrophy, necrosis, the neuron and nerve of defect Colloid.And by inductivity stem cell induce the functional nerve member hypotype with specific neurotransmitter phenotype be cell transplantation and The carrier of gene therapy provides well using means, has a wide range of applications for the treatment of central nervous diseases.
Contain fetal calf serum ingredient in the culture medium of multipotential stem cell culture and differentiating into nerve cells mostly, serum Ingredient is unknown and complicated, since the serum product of different manufacturers is batch widely different, causes the repeatability of experiment extremely low.This Outside, serum is also possible to carry pathogen and other virulence factors, and the nerve cell for greatly reducing differentiation is detected in drug screening Or the application value and safety of cell therapy etc..
Summary of the invention
The purpose of the present invention is on the basis of serum free medium, add a series of substances to promote induced multi-potent dry thin Born of the same parents are applied to drug screening, the foundation of disease model to neural progenitor cell directed differentiation, available a large amount of neural progenitor cell And stem cell regenerating medical domain.
Culture medium of the invention, can will induce multi-potent stem cell to neural progenitor cell break up, inhibit neoblast and Growth to other types cell obtains the neural progenitor cell of high-purity in the later period of differential period, for grinding for scientific research field Study carefully and business application.
The present invention provides a kind of promotions to induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell, tool Body includes serum-free differentiation minimal medium and the additive for promoting neural progenitor cell differentiation.Wherein, serum-free minimal medium, Neccessary composition includes:Basal medium, seralbumin, L-Glutamine, D-Glucose, vitamin C, N2 cell culture addition Agent, B27 cell culture additive and nonessential amino acid.Promote the additive of neural progenitor cell differentiation, specific ingredient includes: SB431542, dermorphin, Fibroblast growth factors 2, vitamin A acid, brain-derived neurotrophic factor.
In one or more embodiments, the basal medium in the minimal medium is selected from DMEM/F12, One or more of Neurobasal, RPMI 1640, DMEM and IMDM culture medium.
In one or more embodiments, seralbumin in the serum-free minimal medium ingredient, L- glutamy The concentration of amine, D-Glucose, vitamin C, N2 cell culture additive, B27 cell culture additive and nonessential amino acid point It is not:Seralbumin is 0.25 g/L-25 g/L, L-Glutamine 1-10nM, D-Glucose 1-10g/L, vitamin C is the N2 cell culture additive of 100-1000 μ g/L, 0.5-5%, the B27 cell culture additive and nonessential ammonia of 0.5-5% Base acid is 10-100 μM.
In one or more embodiments, SB431542 in the additive for promoting neural progenitor cell differentiation, skin coffee The concentration of peptide, Fibroblast growth factors 2, vitamin A acid, brain-derived neurotrophic factor is respectively:SB431542 is 5-30 μM, skin Deltorphin delta is 1-10 μM, and Fibroblast growth factors 2 is 5-30 μ g/L, and vitamin A acid is 1-10 μM, brain-derived neurotrophic factor 1- 10μg/L。
It is proposed using the present invention for promoting to induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell, Its advantage is that:Neural progenitor cell differential medium eliminates animal sources serum composition, reduces the batch sex differernce of differentiation, improves The safety and application value of the neural progenitor cell of source of human stem cell;Neural progenitor cell can be induced from inductivity stem cell to be divided Change, and inducing differentiated system is the mixed system of different cell types, can be helped to improve mixing with cells with this culture medium Neural progenitor cell differentiation in system, reduces the differentiation to other types cell, so that the neural ancestral for finally obtaining high-purity is thin Born of the same parents;The neural progenitor cell that the system prepares can be applied to drug screening, the foundation of disease model and stem cell regenerating Medical domain.
Detailed description of the invention
Fig. 1 is used to detect the marker gene of neural progenitor cell differentiation and maturation(Pax6, Nestin, Oct4)Expression Situation.
Specific embodiment
With reference to the accompanying drawings and examples, more specifically the present invention is illustrated, but should not be considered limited to This embodiment illustrated.
It is basic culture medium with DMEM/F12, adds following component thereto, preparation obtains serum-free minimal medium: The seralbumin of 2.5g/L, the L-Glutamine of 5nM, the D-Glucose of 2g/L, the vitamin C of 200 μ g/L, 1% N2 cell Cultivate additive, 2% B27 cell culture additive, 100 μM of nonessential amino acid.
Promote the additive of neural progenitor cell differentiation, specific constituent concentration is:10 μM of SB431542,1 μM of dermorphin, The Fibroblast growth factors 2 of 10 μ g/L, 1 μM of vitamin A acid, the brain-derived neurotrophic factor of 1 μ g/L.
People induces multi-potent stem cell to be cultivated in serum-free minimal medium system, forms embryoid volume morphing.In base 10 μM of SB431542,1 μM of dermorphin, the Fibroblast growth factors 2 of 10 μ g/L, lasting training are added in basal culture medium system It supports 1 week.Embryoid body cell is subjected to enzymatic hydrolysis separation later, be added in minimal medium system 20 μ g/L at fiber growth because Son -2 carries out adhere-wall culture.
The expression of marker gene relevant to neural progenitor cell differentiation and maturation is detected using real time quantitative PCR method.
As a result as shown in Figure 1, in serum free culture system of the invention, induction versatile stem cell differentiation becomes nerve Progenitor cells.
Above-described embodiment is one embodiment of the present invention, but embodiments of the present invention are not by present embodiment Limitation, it is other it is any without departing from the change made in the case of essence of the invention and principle, substitution, combine, simplification and modification, It should be equivalence replacement mode, be included within the scope of the present invention.

Claims (6)

1. inducing multi-potent stem cell the serum free culture system broken up to neural progenitor cell, which is characterized in that the wherein nothing Serum free culture system system includes serum-free differentiation minimal medium and the additive for promoting neural progenitor cell differentiation.
2. according to claim 1 induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell, spy Sign is that the serum-free differentiation minimal medium includes basal medium and culture medium additive:Basal medium includes One or more of DMEM/F12, Neurobasal, RPMI 1640, DMEM and IMDM culture medium;Culture medium additive includes The seralbumin of 0.25 g/L-25 g/L, the L-Glutamine of 1-10nM, the D-Glucose of 1-10g/L, 100-1000 μ g/L Vitamin C, the N2 cell culture additive of 0.5-5%, the B27 cell culture additive of 0.5-5%, 10-100 μM nonessential Amino acid.
3. according to claim 1 induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell, spy Sign is that the additive for promoting neural progenitor cell differentiation specifically includes:5-30 μM of SB431542,1-10 μM of skin Deltorphin delta, the Fibroblast growth factors 2 of 5-30 μ g/L, 1-10 μM of vitamin A acid, the brain-derived neurotrophic factor of 1-10 μ g/L.
4. serum-free differentiation minimal medium according to claim 2, which is characterized in that the nonessential amino acid choosing From l-Alanine, L-arginine, L-Aspartic acid, altheine, L-cysteine, L-Glutamine, Pidolidone, sweet ammonia One or more of acid, L-Histidine, L-PROLINE, Serine, L- tyrosine.
5. according to claim 1 induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell, spy Sign is, induces multi-potent stem cell in different incubation time points, be added in cultivating system serum-free minimal medium and One or more promote the additive of neural progenitor cell differentiation, persistently cultivate 2 weeks, carry out the analysis of neural progenitor cell maturity.
6. neural progenitor cell maturity analysis according to claim 5, which is characterized in that detection technique includes real-time quantitative PCR and immunostaining.
CN201810817902.2A 2018-07-24 2018-07-24 Induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell Pending CN108823164A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810817902.2A CN108823164A (en) 2018-07-24 2018-07-24 Induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810817902.2A CN108823164A (en) 2018-07-24 2018-07-24 Induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell

Publications (1)

Publication Number Publication Date
CN108823164A true CN108823164A (en) 2018-11-16

Family

ID=64139986

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810817902.2A Pending CN108823164A (en) 2018-07-24 2018-07-24 Induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell

Country Status (1)

Country Link
CN (1) CN108823164A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115125209A (en) * 2022-08-31 2022-09-30 华科星河(北京)生物科技有限公司 Method for inducing cervical spinal cord neural stem cells from induced pluripotent stem cells
CN115125210A (en) * 2022-08-31 2022-09-30 华科星河(北京)生物科技有限公司 Culture medium and method for lumbosacral segment spinal cord neural stem cells induced from iPSC

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102181396A (en) * 2011-03-24 2011-09-14 中国人民解放军第三军医大学第三附属医院 Method for inducing neural stem cells to be directionally differentiated into sensory neurons in vitro
CN103031275A (en) * 2012-11-30 2013-04-10 陆华 Inducing method for differentiating umbilical cord mesenchymal stem cells into neural stem cells
CN106479978A (en) * 2015-10-14 2017-03-08 北京昱龙盛世生物科技有限公司 A kind of special culture media of neural stem cell and its cultural method
CN107254442A (en) * 2017-08-08 2017-10-17 安徽惠恩生物科技股份有限公司 A kind of artificial induction's pluripotent stem cell differentiation is the method for neural precursor
CN107326013A (en) * 2017-07-28 2017-11-07 杨涛 Nerve cell system, abductive approach and application after directional induction hiPSC differentiation
CN107849538A (en) * 2015-03-04 2018-03-27 北卡罗来纳-查佩尔山大学 Method for manufacturing NSC and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102181396A (en) * 2011-03-24 2011-09-14 中国人民解放军第三军医大学第三附属医院 Method for inducing neural stem cells to be directionally differentiated into sensory neurons in vitro
CN103031275A (en) * 2012-11-30 2013-04-10 陆华 Inducing method for differentiating umbilical cord mesenchymal stem cells into neural stem cells
CN107849538A (en) * 2015-03-04 2018-03-27 北卡罗来纳-查佩尔山大学 Method for manufacturing NSC and application thereof
CN106479978A (en) * 2015-10-14 2017-03-08 北京昱龙盛世生物科技有限公司 A kind of special culture media of neural stem cell and its cultural method
CN107326013A (en) * 2017-07-28 2017-11-07 杨涛 Nerve cell system, abductive approach and application after directional induction hiPSC differentiation
CN107254442A (en) * 2017-08-08 2017-10-17 安徽惠恩生物科技股份有限公司 A kind of artificial induction's pluripotent stem cell differentiation is the method for neural precursor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
冯年花等: "人诱导性多能干细胞向神经干细胞分化的方法探讨", 《中国病理生理杂志》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115125209A (en) * 2022-08-31 2022-09-30 华科星河(北京)生物科技有限公司 Method for inducing cervical spinal cord neural stem cells from induced pluripotent stem cells
CN115125210A (en) * 2022-08-31 2022-09-30 华科星河(北京)生物科技有限公司 Culture medium and method for lumbosacral segment spinal cord neural stem cells induced from iPSC
CN115125210B (en) * 2022-08-31 2022-12-02 华科星河(北京)生物科技有限公司 Culture medium and method for lumbosacral segment spinal cord neural stem cells induced from iPSC
CN115125209B (en) * 2022-08-31 2022-12-06 华科星河(北京)生物科技有限公司 Method for inducing cervical spinal cord neural stem cells from induced pluripotent stem cells

Similar Documents

Publication Publication Date Title
Lima et al. Human dental follicle cells express embryonic, mesenchymal and neural stem cells markers
Fu et al. Transformation of human umbilical mesenchymal cells into neurons in vitro
Hatami et al. Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord
Lv et al. Effects of low-intensity pulsed ultrasound on cell viability, proliferation and neural differentiation of induced pluripotent stem cells-derived neural crest stem cells
Tokumoto et al. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro
Takagi et al. Survival and differentiation of neural progenitor cells derived from embryonic stem cells and transplanted into ischemic brain
Zhou et al. Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and stem cell therapy
CN108103021B (en) A kind of preparation method and applications of novel human-derived induction type neural stem cell
CN108315301B (en) A kind of serum free medium of induced nerve stem cells and its application
Abdanipour et al. Induction of adipose-derived stem cell into motoneuron-like cells using selegiline as preinducer
KR101753630B1 (en) Composition for promoting the differentiation of stem cell and proliferation of cell and the method of manufacturing the same
CN108823164A (en) Induce multi-potent stem cell the serum free culture system broken up to neural progenitor cell
JP2023002578A (en) Acceleration of stem cell differentiation
Byun et al. Rapid differentiation of astrocytes from human embryonic stem cells
JP2023038336A (en) Induction of neural progenitor cells, oligodendrocyte progenitor cells and oligodendrocytes by stem cell differentiation using landmark transcription factors
Li et al. Human cord blood-derived multipotent stem cells (CB-SCs) treated with all-trans-retinoic acid (ATRA) give rise to dopamine neurons
Nie et al. Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke
US10472607B2 (en) Culture medium and method for inducing differentiation of pluripotent stem cells into neuroepithelial cells
Llorente et al. Reliable generation of glial enriched progenitors from human fibroblast-derived iPSCs
CN102206611B (en) Isolation and culture method of amniotic-fluid-derived neural stem cells
CN108893444A (en) Induce multi-potent stem cell the serum free culture system broken up to cortical neurogenic cell
Stewart et al. Non‐neural adult stem cells: tools for brain repair?
CN102741398A (en) Methods for producing nerve cells from stem cells, nerve cells and uses thereof
CN105087475B (en) A kind of method that cell culture fluid and its application and induction dental pulp stem cell break up to neural-like cells
CN108949687A (en) Induce multi-potent stem cell the serum free culture system broken up to motor nerve cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20181116

WD01 Invention patent application deemed withdrawn after publication